Found 5 matching trials
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PHASE1The primary objective of this study is to evaluate the safety and clinical ...
Location
Xunyang Changchun Shihua Hospital
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
NAThis is a Phase 1, single-arm, single-center, open-label study to evaluate ...
Location
Cancer hospital Chinese Academy of Medical Sciences
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
PHASE1This is a Phase 1, single-arm, single-center, open-label study to evaluate ...
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PHASE1The primary objective of this study is to evaluate the safety and clinical ...
Location
Affiliated hospital of jiujiang university
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
EARLY_PHASE1This is a Phase 1, single-arm, single-center, open-label study to evaluate ...
Location
Chinese PLA General Hospital